Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Chemical Research in Toxicology

• Publication date

  1999-01-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/TX9802365PMID 10027801
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diclofenac sodium.

  2020cited by this paper
• Selective protein adduct formation of diclofenac glucuronide is critically dependent on the rat canalicular conjugate export pump (Mrp2).

  1998cited by this paper
• Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flurbiprofen, and diclofenac by human liver microsomes.

  1998cited by this paper
• Cytochrome P4502C9: an enzyme of major importance in human drug metabolism.

  1998cited by this paper
• Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes.

  1998cited by this paper
• Cytochrome P4502C11 is a target of diclofenac covalent binding in rats.

  1997cited by this paper
• Oxidation of diclofenac to reactive intermediates by neutrophils, myeloperoxidase, and hypochlorous acid.

  1997cited by this paper
• The use of cultured hepatocytes to investigate the mechanisms of drug hepatotoxicity

  1997cited by this paper
• Sensitivity to a metabolite of diclofenac as a cause of acute immune hemolytic anemia.

  1997cited by this paper
• Recovery from diclofenac-induced hypersensitive fulminant hepatitis and prostaglandins.

  1997cited by this paper
• Immunochemical identification of mouse hepatic protein adducts derived from the nonsteroidal anti-inflammatory drugs diclofenac, sulindac, and ibuprofen.

  1997cited by this paper
• Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes.

  1996cited by this paper
• Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.

  1996cited by this paper
• Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology.

  1995cited by this paper
• Failure of calcium antagonistic agents to prevent hepatotoxicity induced by diclofenac.

  1995cited by this paper
• Diclofenac‐associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions

  1995cited by this paper
• Covalent modification of rat liver dipeptidyl peptidase IV (CD26) by the nonsteroidal anti-inflammatory drug diclofenac.

  1995cited by this paper
• Immunochemical detection of protein adducts in cultured human hepatocytes exposed to diclofenac.

  1995cited by this paper
• Molecular mechanism of diclofenac hepatotoxicity: Association of cell injury with oxidative metabolism and decrease in ATP levels.

  1995cited by this paper
• Analysis of Diclofenac and Four of Its Metabolites in Human Urine by HPLC

  1995cited by this paper
• Cytotoxic activity of T cells and non‐T cells from diclofenac‐immunized mice against cultured syngeneic hepatocytes exposed to diclofenac

  1995cited by this paper
• Selective protein adducts to membrane proteins in cultured rat hepatocytes exposed to diclofenac: radiochemical and immunochemical analysis.

  1994cited by this paper
• Evaluation of triacetyloleandomycin, alpha-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450.

  1994cited by this paper
• Comparative cytotoxicity of non-steroidal anti-inflammatory drugs in primary cultures of rat hepatocytes.

  1994cited by this paper
• Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme.

  1994cited by this paper
• Mechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins. Retention of the glucuronic acid moiety in the adduct.

  1994cited by this paper
• Metabolic activation and immunochemical localization of liver protein adducts of the nonsteroidal anti-inflammatory drug diclofenac.

  1994cited by this paper
• Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs.

  1994cited by this paper
• Immunochemical detection of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenac.

  1993cited by this paper
• Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediated acute cell injury in cultured rat hepatocytes.

  1993cited by this paper
• In vitro methods for assessing human hepatic drug metabolism: their use in drug development.

  1993cited by this paper
• Cytochrome P450TB (CYP2C): a major monooxygenase catalyzing diclofenac 4'-hydroxylation in human liver.

  1993cited by this paper
• Reversible hepatitis associated with diclofenac.

  1991cited by this paper
• Diclofenac hepatitis.

  1991cited by this paper
• Diclofenac hepatitis.

  1991cited by this paper
• Diclofenac-associated hepatotoxicity.

  1990cited by this paper
• Diclofenac associated hepatitis.

  1990cited by this paper
• Immune mechanisms in tienilic acid associated hepatotoxicity.

  1989cited by this paper
• Nucleotide sequence of a human liver cytochrome P-450 related to the rat male specific form.

  1987cited by this paper
• Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.

  1987cited by this paper
• Fatal hepatitis associated with diclofenac.

  1986cited by this paper
• Diclofenac-induced hepatotoxicity.

  1986cited by this paper
• High-performance liquid chromatographic determination of diclofenac and its monohydroxylated metabolites in biological fluids.

  1985cited by this paper
• A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis.

  1984cited by this paper
• N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen.

  1984cited by this paper
• Synthesis, decomposition kinetics, and preliminary toxicological studies of pure N-acetyl-p-benzoquinone imine, a proposed toxic metabolite of acetaminophen.

  1982cited by this paper
• Diclofenac hepatitis.

  1982cited by this paper
• Biotransformation of diclofenac sodium (Voltaren) in animals and in man. I. Isolation and identification of principal metabolites.

  1979cited by this paper
• THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. II. SOLUBILIZATION, PURIFICATION, AND PROPERTIES.

  1964cited by this paper

• Relevance of Reactive Metabolites and Covalent Binding to Drug Candidate Selection.

  2026cites this paper
• Antinociceptive Interaction between Diclofenac and Statins: An Isobolographic Analysis.

  2026cites this paper
• Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes

  2024cites this paper
• Electrochemical Assessment of CYP3A4 Catalytic Activity in Bactosomes

  2024cites this paper
• Antagonistic effects of a COX1/2 inhibitor drug in human HepG2 cells exposed to an environmental carcinogen.

  2024cites this paper
• Diclofenac derivatives as promising anticancer and anti-inflammatory drug: Synthesis, formulations, and pharmacokinetics

  2024cites this paper
• The oxidation of fenamic acid NSAIDs by neutrophil myeloperoxidase produces toxic reactive metabolites that induces leukemic cell death

  2023cites this paper
• Recent developments and applications of ambient mass spectrometry imaging in pharmaceutical research: an overview.

  2023cites this paper
• Metabolism of the aquatic pollutant diclofenac in the Lymnaea stagnalis freshwater gastropod

  2022cites this paper
• Discovery and Optimization of 5-Hydroxy-Diclofenac toward a New Class of Ligands with Nanomolar Affinity for the CaMKIIα Hub Domain.

  2022cites this paper
• Pharmacogenetics of the cytochromes P450: Selected pharmacological and toxicological aspects.

  2022cites this paper
• Effect of cytochrome P450 inhibition on toxicity of diclofenac in chickens: Unravelling toxicity in Gyps vultures

  2022cites this paper
• Human Family 1–4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update

  2021cites this paper
• Identification and Quantification of Transformation Products Formed during the Ozonation of the Non-steroidal Anti-inflammatory Pharmaceuticals Ibuprofen and Diclofenac

  2021cites this paper
• CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs.

  2021cites this paper
• Cytochrome P450 Expression and Chemical Metabolic Activity before Full Liver Development in Zebrafish

  2020cites this paper
• Mass spectrometry imaging of diclofenac and its metabolites in tissues using nanospray desorption electrospray ionization.

  2020cites this paper
• Ozone dose dependent formation and removal of ozonation products of pharmaceuticals in pilot and full-scale municipal wastewater treatment plants.

  2020cites this paper
• Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs

  2020cites this paper
• Human superoxide dismutase 1 attenuates quinoneimine metabolite formation from mefenamic acid.

  2020cites this paper
• Microphysiological heart-liver body-on-a-chip system with a skin mimic for evaluating topical drug delivery.

  2020cites this paper
• Development of Novel Diclofenac Analogs Designed to Avoid Metabolic Activation and Hepatocyte Toxicity

  2020cites this paper
• Diclofenac-induced cytotoxicity in cultured carp leukocytes.

  2020cites this paper
• Effect of probiotic supplementation on oxidative stress markers in rats with diclofenac-induced hepatotoxicity

  2020cites this paper
• Oxidation of diclofenac in the presence of iron(II) octacarboxyphthalocyanine.

  2020cites this paper
• Characterization of the catabolic pathway of diclofenac in Raoultella sp. KDF8

  2019cites this paper
• Biochemical alterations in diclofenac-treated rats: Effect of selenium on oxidative stress, inflammation, and hematological changes

  2019cites this paper
• Quantitative Evaluation of Reactivity and Toxicity of Acyl Glucuronides by [35S]Cysteine Trapping.

  2019cites this paper
• Diclofenac biodegradation by newly isolated Klebsiella sp. KSC: Microbial intermediates and ecotoxicological assessment

  2018cites this paper
• Enhanced laccase-mediated transformation of diclofenac and flufenamic acid in the presence of bisphenol A and testing of an enzymatic membrane reactor

  2018cites this paper
• Drug induced liver injury: assessment of inter-individual variation in the balance of bioactivation and inactivation as risk factor

  2018influential citation
• Chemicals and Drugs Forming Reactive Quinone and Quinone Imine Metabolites.

  2018cites this paper
• In vivo and in vitro diclofenac 5‐hydroxylation mediated primarily by cytochrome P450 3A enzymes in common marmoset livers genotyped for P450 2C19 variants

  2018cites this paper
• Rapid and complete degradation of diclofenac by native soil microorganisms

  2018cites this paper
• Inter-individual variation in hepatic drug metabolism : The potential of in vitro assays in unraveling the role of metabolism in drug induced liver toxicity

  2018cites this paper
• Diclofenac induced gastrointestinal and renal toxicity is alleviated by thymoquinone treatment.

  2018cites this paper
• Effect of diclofenac on the production of volatile fatty acids from anaerobic fermentation of waste activated sludge.

  2018cites this paper
• The Modulatory Role of CYP3A4 in Dictamnine-Induced Hepatotoxicity

  2018cites this paper
• Oxidative Drug Metabolism by Mammalian Cytochrome P450 Enzymes Using Their Monooxygenase and Peroxygenase Functions

  2017cites this paper
• In vitro CYP-mediated drug metabolism in the zebrafish (embryo) using human reference compounds.

  2017cites this paper
• Acyl glucuronide metabolites: Implications for drug safety assessment.

  2017cites this paper
• Metabolic profiling identification of metabolites formed in Mediterranean mussels (Mytilus galloprovincialis) after diclofenac exposure.

  2017cites this paper
• Mycoremediation of diclofenac using Mucor hiemalis

  2017cites this paper
• The self-sufficient P450 RhF expressed in a whole cell system selectively catalyses the 5-hydroxylation of diclofenac.

  2017cites this paper
• Diclofenac in Arabidopsis cells: Rapid formation of conjugates.

  2017cites this paper
• Phase I Metabolic Stability and Electrophilic Reactivity of 2-Phenylaminophenylacetic Acid Derived Compounds.

  2016cites this paper
• Electro-oxidation of diclofenac in methanol as studied by high-performance liquid chromatography/electrospray ionization mass spectrometry.

  2016cites this paper
• Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man

  2016cites this paper
• Pharmacokinetics and pharmacodynamics of diclofenac in the presence and absence of glibenclamide in the rat.

  2016cites this paper
• DRUG METABOLISM BY WHITE ROT FUNGI AND BROWN ROT FUNGI

  2016cites this paper
• Characterization of cytochrome P450 isoforms involved in sequential two-step bioactivation of diclofenac to reactive p-benzoquinone imines.

  2016cites this paper
• Differential sensitivity of metabolically competent and non-competent HepaRG cells to apoptosis induced by diclofenac combined or not with TNF-α.

  2016cites this paper
• Pharmacogenetics in Gastroenterology

  2016cites this paper
• Involvement of Reactive Metabolites of Diclofenac in Cytotoxicity in Sandwich-Cultured Rat Hepatocytes

  2016cites this paper
• Biotic nitrosation of diclofenac in a soil aquifer system (Katari watershed, Bolivia).

  2016cites this paper
• Molecular and Protein characterization of Human cytochrome P450 expressed Recombinant E.Coli and its application in the synthesis of Tramadol metabolite

  2015cites this paper
• Structural basis for the 4′-hydroxylation of diclofenac by a microbial cytochrome P450 monooxygenase

  2015cites this paper
• The guinea‐pig expresses functional CYP2C and P‐glycoprotein: further validation of its usefulness in drug biotransformation/transport studies

  2015cites this paper
• Cytochrome p450 enzymes and electrochemistry: crosstalk with electrodes as redox partners and electron sources.

  2015cites this paper
• Electrocatalytic cycle of P450 cytochromes: the protective and stimulating roles of antioxidants

  2015cites this paper
• The Modulation of Non-steroidal Anti-inflammatory Toxicity as a Function of the Interplay between Uptake and Efflux Transporters

  2015influential citation
• Chemical and Enzymatic Transformations of Nimesulide to GSH Conjugates through Reductive and Oxidative Mechanisms.

  2015cites this paper
• Metabolism related toxicity of diclofenac in yeast as model system

  2015cites this paper
• Mini-dialysis tubes as tools to prepare drug-protein adducts of P450-dependent reactive drug metabolites.

  2015cites this paper
• Transcriptional profiling of reactive metabolites for elucidating toxicological mechanisms: a case study of quinoneimine-forming agents

  2015cites this paper
• Metabolic Activation of the Indoloquinazoline Alkaloids Evodiamine and Rutaecarpine by Human Liver Microsomes: Dehydrogenation and Inactivation of Cytochrome P450 3A4

  2014cites this paper
• Engineered cytochrome P450 BM3 mutants as biocatalysts for metabolite production: Applications in biotechnology and toxicology

  2014cites this paper
• Cytochrome P450-mediated bioactivation of mefenamic acid to quinoneimine intermediates and inactivation by human glutathione S-transferases.

  2014cites this paper
• One-electron oxidation of diclofenac by human cytochrome P450s as a potential bioactivation mechanism for formation of 2'-(glutathion-S-yl)-deschloro-diclofenac.

  2014cites this paper
• A cocktail approach for assessing the in vitro activity of human cytochrome P450s: an overview of current methodologies.

  2014cites this paper
• Applications of NMR Techniques for the Identification and Structure Elucidation of Emerging Organic and Other Xenobiotic Organic Contaminants

  2014cites this paper
• Metabolic Activation of the Indoloquinazoline Alkaloids Evodiamine and Rutaecarpine by Human Liver Microsomes: Dehydrogenation and Inactivation of Cytochrome P450 3A4

  2014cites this paper
• Proposed transformation pathway and evolution profile of diclofenac and ibuprofen transformation products during (sono)photocatalysis

  2014cites this paper
• Chimeric cytochromes P450 engineered by domain swapping and random mutagenesis for producing human metabolites of drugs

  2014influential citation
• Structure-toxicity relationship and structure-activity relationship study of 2-phenylaminophenylacetic acid derived compounds.

  2014cites this paper
• Laccase mediated diclofenac transformation and cytotoxicity assessment on mouse fibroblast 3T3-L1 preadipocytes

  2014cites this paper
• Metabolic Activation of the Indoloquinazoline Alkaloids Evodiamine and Rutaecarpine by Human Liver Microsomes: Dehydrogenation and Inactivation of Cytochrome P450 3A4 s

  2014cites this paper
• HPLC–MS Profiling and Structural Identification of [14C]-Diclofenac Metabolites in Mouse Bile

  2014cites this paper
• Metabolic Activation of the Indoloquinazoline Alkaloids Evodiamine and Rutaecarpine by Human Liver Microsomes: Dehydrogenation and Inactivation of Cytochrome P450 3A4 s

  2014cites this paper
• Uptake and metabolism of diclofenac in Typha latifolia--how plants cope with human pharmaceutical pollution.

  2014cites this paper
• Drug interactions of diclofenac and its oxidative metabolite with human liver microsomal cytochrome P450 1A2-dependent drug oxidation

  2014influential citation
• Electrochemistry/mass spectrometry as a tool in metabolism studies-a review.

  2014cites this paper
• Human NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated inactivation of reactive quinoneimine metabolites of diclofenac and mefenamic acid.

  2014cites this paper
• Drug Response Heterogeneity and the Genetic Variability of Cytochrome P450–Metabolizing Enzymes

  2014cites this paper
• The role of CYP2C9 genetic polymorphisms in the oxidative metabolism of diclofenac in vitro.

  2014cites this paper
• Mini-dialysis tubes as tools to prepare drug-protein adducts of cytochrome P450-dependent reactive drug metabolites

  2013cites this paper
• Mechanisms Underlying the Hepatotoxicity of Nonsteroidal Antiinflammatory Drugs

  2013cites this paper
• Role of drug-independent stress factors in liver injury associated with diclofenac intake.

  2013cites this paper
• Role of genetic polymorphisms of drug metabolising enzymes in idiosyncratic drug reactions In vitro to in vivo translation

  2013cites this paper
• Mass spectrometric characterization of protein adducts of multiple cytochrome P450-dependent reactive intermediates of diclofenac to human glutathione-S- transferase P1-1

  2013cites this paper
• Glutathione-S-transferases: tools and targets for characterization of chemically reactive drug metabolites

  2013cites this paper
• Effect of human glutathione S-transferases on glutathione-dependent inactivation of cytochrome P450-dependent reactive intermediates of diclofenac.

  2013cites this paper
• The hepatic reductase null mouse as a model for exploring hepatic conjugation of xenobiotics: Application to the metabolism of diclofenac

  2012cites this paper
• In vitro and in vivo investigations into the interactions between the acyl glucuronide metabolite of diclofenac and serum albumin

  2012cites this paper
• Differential involvement of mitochondrial dysfunction, cytochrome P450 activity, and active transport in the toxicity of structurally related NSAIDs.

  2012cites this paper
• Mass spectrometric characterization of protein adducts of multiple P450-dependent reactive intermediates of diclofenac to human glutathione-S-transferase P1-1.

  2012cites this paper
• Increase in covalent binding of 5-hydroxydiclofenac to hepatic tissues in rats co-treated with lipopolysaccharide and diclofenac: involvement in the onset of diclofenac-induced idiosyncratic hepatotoxicity.

  2012influential citation
• Simulation of the oxidative metabolism of diclofenac by electrochemistry/(liquid chromatography/)mass spectrometry

  2012cites this paper
• Pathways of Reactive Metabolite Formation with Toxicophores/‐Structural Alerts

  2012cites this paper
• The influence of B-group vitamins on monooxygenase activity of cytochrome P450 3A4: Pharmacokinetics and electro analysis of the catalytic properties

  2012cites this paper